Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2013 (2013), Article ID 640632, 6 pages
Research Article

Glucose Lowering Therapeutic Strategies for Type 2 Diabetic Patients with Chronic Kidney Disease in Primary Care Setting in France: A Cross-Sectional Study

1IMS Health France, 5-7 Place de la Pyramide, 92088 Paris La Défense, France
2Cemka-Eval, 43 Boulevard du Maréchal Joffre, 92340 Bourg-la-Reine, France
3Medical office, 4 Rue de L’Ile de France, 91860 Epinay sous Senart, France
4Nephrology Department, Hôpital Necker-Enfants Malades, 149 Rue de Sèvres, 75015 Paris, France
5Diabetes Department, Hôpital de la Pitié-Salpétrière, 47 Boulevard de l’Hôpital, 75013 Paris, France
6INSERM CESP, U-1018, Villejuif, 94800, France
7Endocrinology Department, Hôpital du Bocage, 1 Boulevard Jeanne d'Arc, 21079 Dijon, France
8Boehringer-Ingelheim France, 14 Rue Jean Antoine de Baïf, 75013 Paris, France

Received 4 January 2013; Accepted 20 February 2013

Academic Editor: Ilias Migdalis

Copyright © 2013 N. Grandfils et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. National Diabetes Statistics, National Diabetes Information Clearinghouse [Internet], 2011,
  2. P. Ricci, P. O. Blotiere, A. Weill, D. Simon, P. Tuppin, and P. Ricordeau, “Diabète traité: quelles évolutions entre 2000 et 2009 en France?” Bulletin Epidémiologique Hebdomadaire, vol. 42-43, pp. 425–431, 2010. View at Google Scholar
  3. CNAMTS, “Propositions de l’Assurance Maladie sur les charges et produits pour l’année 2013 [Internet],” Caisse Nationale d’Assurance Maladie des Travailleurs Salariés, 2012,
  4. CDC, National Chronic Kidney Disease Fact Sheet 2010—Factsheets—Publication—Diabetes DDT [Internet],
  5. B. Radbill, B. Murphy, and D. LeRoith, “Rationale and strategies for early detection and management of diabetic kidney disease,” Mayo Clinic Proceedings, vol. 83, no. 12, pp. 1373–1381, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. L. C. Plantinga, D. C. Crews, J. Coresh et al., “Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes,” Clinical Journal of the American Society of Nephrology, vol. 5, no. 4, pp. 673–682, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. C. E. Lok, M. J. Oliver, D. M. Rothwell, and J. E. Hux, “The growing volume of diabetes-related dialysis: a population based study,” Nephrology Dialysis Transplantation, vol. 19, no. 12, pp. 3098–3103, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Ritz, I. Rychlík, F. Locatelli, and S. Halimi, “End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions,” The American Journal of Kidney Diseases, vol. 34, no. 5, pp. 795–808, 1999. View at Google Scholar · View at Scopus
  9. M. Lassalle and C. Couchoud, “Réseau Epidémiologie et Information en Néphrologie [Internet],” Saint Denis: Agence de la Biomédecine, 2010,
  10. “KDOQI Guidelines [Internet],”
  11. V. Ertel-Pau and V. Raimond, “Stratégie médicamenteuse du contrôle glycémique du diabète de type 2,” Médecine Thérapeutique, vol. 18, no. 1, pp. 41–53, 2012. View at Google Scholar
  12. E. S. Huang, J. Y. Liu, H. H. Moffet, P. M. John, and A. J. Karter, “Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study,” Diabetes Care, vol. 34, no. 6, pp. 1329–1336, 2011. View at Publisher · View at Google Scholar
  13. C. E. Koro, B. H. Lee, and S. J. Bowlin, “Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States,” Clinical Therapeutics, vol. 31, no. 11, pp. 2608–2617, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. A. S. Go, G. M. Chertow, D. Fan, C. E. McCulloch, and C. Y. Hsu, “Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization,” The New England Journal of Medicine, vol. 351, no. 13, pp. 1296–1305, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. G. F. A. Assogba, C. Couchoud, C. Roudier et al., “Prevalence, screening and treatment of chronic kidney disease in people with type 2 diabetes in France: the ENTRED surveys (2001 and 2007),” Diabetes and Metabolism, vol. 38, no. 6, pp. 558–566, 2012. View at Publisher · View at Google Scholar
  16. H. Becher, K. Kostev, and D. Schröder-Bernhardi, “Validity and representativeness of the “disease analyzer” patient database for use in pharmacoepidemiological and pharmacoeconomic studies,” International Journal of Clinical Pharmacology, vol. 47, no. 10, pp. 617–626, 2009. View at Google Scholar
  17. A. Sharif, “Current and emerging antiglycaemic pharmacological therapies: the renal perspective,” Nephrology, vol. 16, no. 5, pp. 468–475, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Oulahiane, S. Anaddam, H. Ouleghzal et al., “Diabetes management issues for patients with chronic kidney disease,” Nephrologie and Therapeutique, vol. 8, no. 3, pp. 135–140, 2012. View at Google Scholar
  19. T. M. Islam, C. S. Fox, D. Mann, and P. Muntner, “Age-related associations of hypertension and diabetes mellitus with chronic kidney disease,” BMC Nephrology, vol. 10, no. 1, article 17, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Bonnet, E. Gauthier, H. Gin et al., “Expert consensus on management of diabetic patients with impairment of renal function,” Diabetes and Metabolism, vol. 37, supplement 2, pp. 1–25, 2011. View at Google Scholar
  21. American Diabetes Association, “Standards of Medical Care in Diabetes–2012,” Diabetes Care, vol. 35, supplement 1, pp. S11–S63, 2012. View at Publisher · View at Google Scholar
  22. “Type 2 Diabetes—newer agents (partial update of CG66) [Internet],”
  23. S. E. Inzucchi, R. M. Bergenstal, J. B. Buse et al., “Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American diabetes association (ADA) and the european association for the study of diabetes (EASD),” Diabetologia, vol. 55, no. 6, pp. 1577–1596, 2012. View at Publisher · View at Google Scholar